ANI Pharmaceuticals | ANIP - Ebit


ANI Pharmaceuticals reported $29.13M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Aurora Cannabis CAD -35.79M 8.96M Dec/2025
Canopy Growth CAD -12.66M 1.64M Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Heron Therapeutics USD 38K 3.83M Dec/2025
Hikma Pharmaceutical USD 348M 31M Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Novartis USD 4.06B 413M Dec/2025
Omeros USD -48.15M 7.25M Sep/2023
Perrigo USD 84.4M 9M Dec/2025
Sun Pharmaceuticals INR 40.62B 6.95B Dec/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025